Organization | The Research Grants Council, Hong Kong

The Research Grants Council, Hong Kong Report issue

Government

Organization Overview

First Clinical Trial

2008

NCT00792051

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2019

Timeline

NOW

Now

Alternative names

Research Grants Council, Hong Kong

Active Ingredients

Drugs in Other Trials (4)

casein phosphopeptide amorphous calcium phosphate (1 trial)

inactivated influenza vaccine (1 trial)

sodium chloride (1 trial)

sodium fluoride (18F) (1 trial)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 2
# of Trial APIs: 4